{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:37:58Z","timestamp":1788871078804,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1032325"],"award-info":[{"award-number":["OPP1032325"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jim.2014.04.005","type":"journal-article","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T21:15:44Z","timestamp":1398719744000},"page":"107-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials"],"prefix":"10.1016","volume":"409","author":[{"given":"Anna","family":"Sambor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrosia","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Berrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Pickeral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wes","family":"Rountree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Pollara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Frahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Keinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo H.","family":"Kijak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Roederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Patricia","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Jaimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Koup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Denny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2014.04.005_bb0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2796.2008.02045.x","article-title":"NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection","volume":"265","author":"Alter","year":"2009","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jim.2014.04.005_bb0010","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.tim.2012.08.011","article-title":"HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design","volume":"20","author":"Bonsignori","year":"2012","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jim.2014.04.005_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2012.07.010","article-title":"T cell assays and MIATA: The essential minimum for maximum impact","volume":"37","author":"Britten","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jim.2014.04.005_bb0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jim.2007.02.003","article-title":"Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials","volume":"322","author":"Bull","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2014.04.005_bb0160","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1089\/aid.2005.21.68","article-title":"Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials","volume":"21","author":"Cox","year":"2005","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jim.2014.04.005_bb0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-1759(01)00535-X","article-title":"A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays","volume":"260","author":"Currier","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2014.04.005_bb0035","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1128\/JVI.00171-11","article-title":"An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum","volume":"85","author":"Ferrari","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2014.04.005_bb0040","doi-asserted-by":"crossref","first-page":"e14330","DOI":"10.1371\/journal.pone.0014330","article-title":"Equivalence of ELISpot assays demonstrated between major HIV network laboratories","volume":"5","author":"Gill","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2014.04.005_bb0165","doi-asserted-by":"crossref","first-page":"1237874","DOI":"10.1126\/science.1237874","article-title":"Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms","volume":"340","author":"Hansen","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jim.2014.04.005_bb0050","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2014.04.005_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jim.2007.03.002","article-title":"Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination","volume":"323","author":"Horton","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2014.04.005_bb0060","first-page":"13","article-title":"Structured reporting of T cell assay results","volume":"13","author":"Janetzki","year":"2013","journal-title":"Cancer Immun."},{"key":"10.1016\/j.jim.2014.04.005_bb0065","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/nprot.2006.268","article-title":"Intracellular cytokine optimization and standard operating procedure","volume":"1","author":"Lamoreaux","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jim.2014.04.005_bb0070","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1016\/j.vaccine.2006.06.009","article-title":"Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation","volume":"24","author":"Li","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2014.04.005_bb0075","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.immuni.2013.08.031","article-title":"Human circulating PD-1+CXCR3\u2212CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses","volume":"39","author":"Locci","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jim.2014.04.005_bb0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-065X.2010.00968.x","article-title":"Living in a house of cards: re-evaluating CD8+ T-cell immune correlates against HIV","volume":"239","author":"Makedonas","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jim.2014.04.005_bb0085","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1128\/CVI.00492-09","article-title":"Quality monitoring of HIV-1-infected and uninfected peripheral blood mononuclear cell samples in a resource-limited setting","volume":"17","author":"Olemukan","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2014.04.005_bb0090","doi-asserted-by":"crossref","first-page":"e30963","DOI":"10.1371\/journal.pone.0030963","article-title":"International technology transfer of a GCLP-compliant HIV-1 neutralizing antibody assay for human clinical trials","volume":"7","author":"Ozaki","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2014.04.005_bb0095","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/nprot.2006.250","article-title":"Quality assurance for polychromatic flow cytometry","volume":"1","author":"Perfetto","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jim.2014.04.005_bb0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jim.2006.04.007","article-title":"Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry","volume":"313","author":"Perfetto","year":"2006","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2014.04.005_bb0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jim.2014.04.005_bb0110","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/cid\/cit048","article-title":"Complex correlates of protection after vaccination","volume":"56","author":"Plotkin","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jim.2014.04.005_bb0115","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/cyto.a.21084","article-title":"High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses","volume":"79A","author":"Pollara","year":"2011","journal-title":"Cytometry A"},{"key":"10.1016\/j.jim.2014.04.005_bb0170","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/CDLI.7.3.352-359.2000","article-title":"Preservation of Lymphocyte Immunophenotype and Proliferative Responses in Cryopreserved Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1-Infected Donors: Implications for Multicenter Clinical Trials","volume":"7","author":"Reimann","year":"2000","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2014.04.005_bb0125","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/367702","article-title":"Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity","volume":"187","author":"Russell","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2014.04.005_bb0130","doi-asserted-by":"crossref","first-page":"e1000067","DOI":"10.1371\/journal.pmed.1000067","article-title":"Evaluation and recommendations on good clinical laboratory practice guidelines for phase I\u2013III clinical trials","volume":"6","author":"Sarzotti-Kelsoe","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.jim.2014.04.005_bb0135","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1074\/jbc.M009483200","article-title":"High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R","volume":"276","author":"Shields","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2014.04.005_bb0175","doi-asserted-by":"crossref","first-page":"a007054","DOI":"10.1101\/cshperspect.a007054","article-title":"The T-cell response to HIV","volume":"2","author":"Walker","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jim.2014.04.005_bb0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jim.2013.05.007","article-title":"Optimization and qualification of a memory B-cell ELISpot for the detection of vaccine-induced memory responses in HIV vaccine trials","volume":"394","author":"Walsh","year":"2013","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2014.04.005_bb0185","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/CVI.00342-08","article-title":"Pediatric ACTG Cryopreservation Working Group, 2009. Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization","volume":"16","author":"Weinberg","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2014.04.005_bb0155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jim.2010.09.032","article-title":"Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays","volume":"363","author":"Weinberg","year":"2010","journal-title":"J. Immunol. Methods"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175914001227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175914001227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T11:23:31Z","timestamp":1538652211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175914001227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":31,"alternative-id":["S0022175914001227"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2014.04.005","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2014.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}